{"date":"2025-03-31","count":33,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7724-2025-03-31-2330-bwopfv","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"23:30:55","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2025-03-31 23:30，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2025-03-31-2323-1hku5w3","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"23:23:40","subject":"公告本公司董事會通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2025-03-31 23:23，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2025-03-31-2322-1m7d12f","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"23:22:14","subject":"本公司董事會決議114年股東常會召開事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2025-03-31 23:22，「本公司董事會決議114年股東常會召開事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2025-03-31-1850-16d6afs","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"18:50:25","subject":"公告本公司114年2月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2025-03-31 18:50，「公告本公司114年2月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-03-31-1831-8ew7ca","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-03-31","time":"18:31:47","subject":"本公司因策略考量，決議提前終止社區型肺炎二期臨床試驗收案。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-03-31 18:31，「本公司因策略考量，決議提前終止社區型肺炎二期臨床試驗收案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2025-03-31-1828-feejwx","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"18:28:13","subject":"代重要子公司育禾管理顧問股份有限公司公告董事會決議113年度累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2025-03-31 18:28，「代重要子公司育禾管理顧問股份有限公司公告董事會決議113年度累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2025-03-31-1828-dgi9r8","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"18:28:02","subject":"代重要子公司育禾管理顧問股份有限公司公告董事會決議召開114年股東常會(新增)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2025-03-31 18:28，「代重要子公司育禾管理顧問股份有限公司公告董事會決議召開114年股東常會(新增)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2025-03-31-1823-1tllx0o","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"18:23:42","subject":"更正公告本公司董事會通過113年度合併財務報告(誤植營業損失金額及期末總負債金額)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2025-03-31 18:23，「更正公告本公司董事會通過113年度合併財務報告(誤植營業損失金額及期末總負債金額)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2025-03-31-1821-26cgtk","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"18:21:36","subject":"公告本公司配合會計師事務所內部調整變更簽證會計師","clause":"第7款","fact_date":"2025-03-31","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2025-03-31 18:21，「公告本公司配合會計師事務所內部調整變更簽證會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2025-03-31-1819-io8xzp","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"18:19:58","subject":"本公司財務及會計主管異動","clause":"第11款","fact_date":"2025-03-31","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2025-03-31 18:19，「本公司財務及會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2025-03-31-1818-18vwz7f","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"18:18:47","subject":"本公司新任薪資報酬委員會委員","clause":"第6款","fact_date":"2025-03-31","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2025-03-31 18:18，「本公司新任薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2025-03-31-1817-10fn4ra","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"18:17:29","subject":"公告本公司董事會重大決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2025-03-31 18:17，「公告本公司董事會重大決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2025-03-31-1814-1ugpgsp","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"18:14:30","subject":"公告本公司董事會決議召開民國113年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2025-03-31 18:14，「公告本公司董事會決議召開民國113年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2025-03-31-1812-8v65xz","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"18:12:13","subject":"本公司董事會決議通過113年度股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2025-03-31 18:12，「本公司董事會決議通過113年度股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2025-03-31-1810-1hku5w3","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"18:10:18","subject":"公告本公司董事會通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2025-03-31 18:10，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-03-31-1806-1roellr","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"18:06:26","subject":"公告本公司董事辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-03-31 18:06，「公告本公司董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-03-31-1800-1n71c89","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"18:00:58","subject":"公告本公司會計主管、發言人及代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-03-31 18:00，「公告本公司會計主管、發言人及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-03-31-1753-wr0tu2","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"17:53:51","subject":"公告本公司總經理異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-03-31 17:53，「公告本公司總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-03-31-1732-jhv257","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"17:32:45","subject":"公告本公司114年第一次私募普通股訂價相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-03-31 17:32，「公告本公司114年第一次私募普通股訂價相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-03-31-1722-drgvb6","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"17:22:40","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-03-31 17:22，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-03-31-1709-poa6px","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"17:09:11","subject":"公告本公司董事會決議不分配113年度員工酬勞及董事酬勞","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-03-31 17:09，「公告本公司董事會決議不分配113年度員工酬勞及董事酬勞」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-03-31-1650-11wjw0o","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-03-31","time":"16:50:32","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-03-31 16:50，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-03-31-1647-1ib5ngg","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"16:47:48","subject":"公告本公司董事會決議113年度不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-03-31 16:47，「公告本公司董事會決議113年度不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-03-31-1627-1x9xanp","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-03-31","time":"16:27:19","subject":"公告本公司董事會決議召開股東會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-03-31 16:27，「公告本公司董事會決議召開股東會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-03-31-1624-x67rvv","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-03-31","time":"16:24:32","subject":"本公司董事會決議辦理初次上市掛牌前現金增資發行新股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-03-31 16:24，「本公司董事會決議辦理初次上市掛牌前現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-03-31-1621-kfko1e","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-03-31","time":"16:21:54","subject":"公告本公司現金股利除息基準日、發放日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-03-31 16:21，「公告本公司現金股利除息基準日、發放日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-03-31-1620-hqo89","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"16:20:45","subject":"公告本公司113度會計師出具無保留意見加繼續經營有關之重大不確定性段落之查核報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-03-31 16:20，「公告本公司113度會計師出具無保留意見加繼續經營有關之重大不確定性段落之查核報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-03-31-1618-1xrs60h","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-03-31","time":"16:18:55","subject":"代重要子公司意能生技股份有限公司公告董事會決議辦理現金增資發行新股事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-03-31 16:18，「代重要子公司意能生技股份有限公司公告董事會決議辦理現金增資發行新股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-03-31-1617-bjl9h4","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"16:17:36","subject":"公告本公司副總經理辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-03-31 16:17，「公告本公司副總經理辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-03-31-1608-1dmdgdo","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"16:08:29","subject":"公告本公司董事會通過113年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-03-31 16:08，「公告本公司董事會通過113年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-03-31-1514-1t5gay1","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-03-31","time":"15:14:53","subject":"本公司受邀參加櫃買中心舉辦之業績發表會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-03-31 15:14，「本公司受邀參加櫃買中心舉辦之業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2025-03-31-1439-liszy","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2025-03-31","time":"14:39:10","subject":"更正本公司113年度合併財務報告附註附表七、大陸投資資訊及個體財務報告附註附表六、大陸投資資訊部分資訊","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2025-03-31 14:39，「更正本公司113年度合併財務報告附註附表七、大陸投資資訊及個體財務報告附註附表六、大陸投資資訊部分資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6848-2025-03-31-1416-cdcxdi","company_id":"6848","company":"拉法醫","market":"興櫃","industry":"生技醫療","date":"2025-03-31","time":"14:16:29","subject":"公告本公司董事會決議113年度員工酬勞及董事酬勞分派案(原重訊主旨年度誤植更正正確年度)","clause":"第44款","fact_date":"2025-03-28","cite_as":"公開資訊觀測站重大訊息：拉法醫（6848），2025-03-31 14:16，「公告本公司董事會決議113年度員工酬勞及董事酬勞分派案(原重訊主旨年度誤植更正正確年度)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}